Tempus Publishes Study Highlighting Benefits of Concurrent RNA …
3 days ago · CHICAGO--(BUSINESS WIRE)--Nov. 11, 2024-- Tempus AI, Inc. (NASDAQ: TEM), a technology company leading the adoption of AI to advance precision medicine and patient care, today announced publication of its study, “Actionable structural variant detection via RNA-NGS and DNA-NGS in patients with advanced non-small cell lung cancer,” in JAMA Network Open.
Press Releases | News | Tempus
Tempus AI, Inc. (NASDAQ: TEM), a technology company leading the adoption of AI to advance precision medicine and patient care, today announced the beta launch of a patient-facing app, olivia, an AI-enabled personal health concierge to empower individuals to holistically organize, manage, and proactively take control of their own health data. oli...
Tempus Molecular Profiling Integration Now Available Through …
2 days ago · CHICAGO--(BUSINESS WIRE)--Nov. 12, 2024-- Tempus AI, Inc. (NASDAQ: TEM), a technology company leading the adoption of AI to advance precision medicine and patient care, today announced the collaboration with Flatiron Health, a leading healthtech company dedicated to expanding the possibilities of point of care solutions in oncology, to integrate its comprehensive genomic testing directly into ...
Tempus AI, Inc.: Valuation Concerns and Growth Uncertainties …
3 days ago · Nov. 11, 2024, 03:35 AM. Stifel Nicolaus analyst Daniel Arias downgraded the rating on Tempus AI, Inc. Class A (TEM – Research Report) to a Hold yesterday, setting a price target of $65.00 ...
Tempus AI Inc (TEM) Q3 2024 Earnings Call Highlights: Robust …
Nov 5, 2024 · Tempus AI Inc reported a 33% revenue growth, reaching $180.9 million for Q3 2024. The company's data and services revenue accelerated to 64.4% year-over-year growth, with the data licensing ...
Tempus AI Reports Growth and Strategic Acquisition
Nov 5, 2024 · The company reported a 33% year-over-year revenue growth reaching $180.9 million, with accelerated growth in its data and services segment at 64.4%. Despite a net loss of $75.8 million, Tempus ...
Google-backed Tempus AI closes first day of trading up 9% in …
Jun 14, 2024 · Tempus AI, a health-care diagnostics company that uses AI to interpret medical tests to help physicians provide more accurate treatment for their patients, rose by as much as 15% in its...
Tempus rises 9% on the first day of trading, demonstrating …
Jun 14, 2024 · Tempus rises 9% on the first day of trading, demonstrating investor appetite for a health tech with a promise of AI. Tempus, a genomic testing and data analysis company started by Eric...
Medical Data Firm Tempus AI Rises After $410.7 Million IPO
Jun 14, 2024 · Tempus AI Inc., a technology platform company using artificial intelligence to process medical data, jumped as much as 19% in its trading debut before falling closer the price in its $410.7...
Tempus Expands Immuno-Oncology Portfolio with Launch of AI …
CHICAGO, July 16, 2024 -- (BUSINESS WIRE)--Tempus AI, Inc. (NASDAQ: TEM), a leader in artificial intelligence and precision medicine, today announced that its multimodal immune profile score...